Deployment of Physician Resources and Innovative Medical Strategies in the 2023–2024 Israel–Hamas War: Israel’s Strategy to Deliver Advanced Life Support and Whole Blood Transfusion to the Battlefield via Forward Medical Teams and the Impact on the Case Fatality Rate
Military Medicine · 01.09.2025 · 190 (9-10) · 226-230
DOI: 10.1093/milmed/usae553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, online erschienen am 13.12.2024. Verfasst von Daniel Katzman und 3 weiteren Autor:innen. Beteiligte Einrichtung: DKNYMD Medical Consulting Ltd, Modiin-Macabim-Reut 7173344, Israel. Hauptthemen laut MEDLINE: Blood Transfusion, Warfare, Physicians. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
The 2023–2024 Israel–Hamas War, which began following a Hamas attack on Israel on October 7, 2023, has seen a case fatality rate (CFR) among the lowest in the history of warfare. In resultant ground maneuvers, the Israel Defense Forces Medical Corps (IDF-MC) doctrine for the delivery of combat casualty care has been battle tested. We suggest the decreased CFR in part reflects a paradigm shift in combat deployment of medical resources, so as to introduce life-saving strategies not previously seen on the battlefield in large scale to date. These changes, which began in the 2006 Lebanon war and have been in evolution since, include strategic physician deployment to positions more forward than in previous wars and in teams smaller than the previous standard. These forward medical teams have replaced the battalion aid station in the Gaza theater of operations and serve to increase the availability of Advanced Life Support (ALS) level care at the point of injury, wherever a casualty might be on a multidimensional battlefield. These forward medical teams deploy with advanced medical capabilities, including in some cases the ability to transfuse low titer O whole blood. This article reviews aspects of the IDF-MC combat casualty care doctrine as implemented during the current war, the role and advantages of transfusion-capable ALS forward medical teams, and the apparent impact on the CFR thereof.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- DKNYMD Medical Consulting Ltd, Modiin-Macabim-Reut 7173344, Israel.
- Hebrew University of Jerusalem College of Medicine, Tzameret Track, Campus Ein Kerem, Jerusalem 9112102, Israel.
- Israel Defense Forces Medical Corps, Surgeon General's Headquarters, Israel Defense Forces, Ramat Gan 5262000, Israel.
- Department of Military Medicine, Faculty of Medicine, Hebrew University, Jerusalem 9574869, Israel.
- Chief Medical Officer of The Southern Command, Israel Defense Forces, Medical Corps, Ramat Gan 5262000, Israel.
ORCID-Profile: Daniel Katzman, Ofer Almog
Zitieren
APA
Katzman, D., Kalman, G., Almog, O., & Fogel, I. (2025). Deployment of Physician Resources and Innovative Medical Strategies in the 2023–2024 Israel–Hamas War: Israel’s Strategy to Deliver Advanced Life Support and Whole Blood Transfusion to the Battlefield via Forward Medical Teams and the Impact on the Case Fatality Rate. Military Medicine, 190(9-10), 226-230. https://doi.org/10.1093/milmed/usae553
Vancouver
Katzman D, Kalman G, Almog O, Fogel I. Deployment of Physician Resources and Innovative Medical Strategies in the 2023–2024 Israel–Hamas War: Israel’s Strategy to Deliver Advanced Life Support and Whole Blood Transfusion to the Battlefield via Forward Medical Teams and the Impact on the Case Fatality Rate. Military Medicine. 2025;190(9-10):226-230. doi:10.1093/milmed/usae553
BibTeX
@article{Katzman2025,
author = {Katzman, Daniel and Kalman, Gefen and Almog, Ofer and Fogel, Itay},
title = {Deployment of Physician Resources and Innovative Medical Strategies in the 2023–2024 Israel–Hamas War: Israel’s Strategy to Deliver Advanced Life Support and Whole Blood Transfusion to the Battlefield via Forward Medical Teams and the Impact on the Case Fatality Rate},
journal = {Military Medicine},
year = {2025},
volume = {190},
number = {9-10},
pages = {226--230},
doi = {10.1093/milmed/usae553}
}
EUVIMED